Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ALKS

Alkermes

$42.53

-0.43 (-1.00%)

13:14
04/16/18
04/16
13:14
04/16/18
13:14
Recommendations
Alkermes analyst commentary at Credit Suisse »

Alkermes price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 08

    May

  • 21

    May

  • 31

    Jan

ALKS

Alkermes

$42.53

-0.43 (-1.00%)

11:32
04/16/18
04/16
11:32
04/16/18
11:32
Recommendations
Alkermes analyst commentary at Goldman Sachs »

FDA filing acceptance an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 08

    May

  • 21

    May

  • 31

    Jan

ALKS

Alkermes

$42.53

-0.43 (-1.00%)

, BAC

Bank of America

$29.80

-0.85 (-2.77%)

09:06
04/16/18
04/16
09:06
04/16/18
09:06
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Alkermes (ALKS),…

ALKS

Alkermes

$42.53

-0.43 (-1.00%)

BAC

Bank of America

$29.80

-0.85 (-2.77%)

WPP

WPP

$84.53

0.41 (0.49%)

ERI

Eldorado Resorts

$35.70

0.2 (0.56%)

TPCA

Tropicana

ALGT

Allegiant Travel

$151.05

-14.2 (-8.59%)

DVAX

Dynavax

$19.75

-1 (-4.82%)

LOXO

Loxo Oncology

$122.99

-3.25 (-2.57%)

BPMC

Blueprint Medicines

$98.98

-2.2 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 16

    Apr

  • 16

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 03

    May

  • 08

    May

  • 21

    May

  • 12

    Jun

ALKS

Alkermes

$42.52

-0.46 (-1.07%)

07:31
04/16/18
04/16
07:31
04/16/18
07:31
Technical Analysis
Technical Take: Alkermes jumps after FDA rescinds Refusal to File letter »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 21

    May

ALKS

Alkermes

$42.53

-0.43 (-1.00%)

07:16
04/16/18
04/16
07:16
04/16/18
07:16
Hot Stocks
Breaking Hot Stocks news story on Alkermes »

Alkermes jumps 21% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 21

    May

ALKS

Alkermes

$42.53

-0.43 (-1.00%)

07:04
04/16/18
04/16
07:04
04/16/18
07:04
Hot Stocks
FDA rescinds Refusal to File letter for Alkermes depression drug »

Alkermes announced this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 21

    May

ALKS

Alkermes

$42.53

-0.43 (-1.00%)

06:57
04/16/18
04/16
06:57
04/16/18
06:57
Hot Stocks
Alkermes announces FDA acceptance for ALKS 5461 NDA »

Alkermes announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 21

    May

Over a week ago
ITCI

Intra-Cellular

$19.38

-1.675 (-7.96%)

, ALKS

Alkermes

$45.23

-12.73 (-21.96%)

07:47
04/03/18
04/03
07:47
04/03/18
07:47
Recommendations
Intra-Cellular, Alkermes analyst commentary at Leerink »

Intra-Cellular selloff on…

ITCI

Intra-Cellular

$19.38

-1.675 (-7.96%)

ALKS

Alkermes

$45.23

-12.73 (-21.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

ITCI

Intra-Cellular

$19.38

-1.675 (-7.96%)

, ALKS

Alkermes

$45.23

-12.73 (-21.96%)

07:37
04/03/18
04/03
07:37
04/03/18
07:37
Recommendations
Intra-Cellular, Alkermes analyst commentary at Canaccord »

Intra-Cellular weakness a…

ITCI

Intra-Cellular

$19.38

-1.675 (-7.96%)

ALKS

Alkermes

$45.23

-12.73 (-21.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

ALKS

Alkermes

$45.23

-12.73 (-21.96%)

06:33
04/03/18
04/03
06:33
04/03/18
06:33
Recommendations
Alkermes analyst commentary at JPMorgan »

Alkermes price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.